Given the limited improvement typically obtained
in treatment studies that use peer report measures as outcomes with ADHD samples and the well - documented predictive validity of peer reports for later adjustment, the need for more intensive interventions and novel approaches to address the peer problems of children with ADHD is emphasized.
Within the past 15 years, a new psychosocial treatment termed dialectical behavior therapy (DBT) was developed specifically to treat BPD, and this technique has looked promising
in treatment studies.
The teacher ratings weren't strong enough to be significant, although significance among teacher measures is hardly ever found
in any treatment studies.
9 HW +
in our Treatment Study.
Investigation of therapeutic alliance
in a treatment study with substance - abusing women with PTSD.
Couples were recruited for participation
in a treatment study focusing on depression from 2001 until 2006.
We further explain our complicated grief model and provide results of a study of 128 participants
in a treatment study of CG who completed a 15 - item Grief - related Avoidance Questionnaire (GRAQ).
Not exact matches
An important trigger this year will be the outcome of a
study where Darzalex is being tested as first - line
treatment in combination with Celgene Corp's Revlimid.
It
studies DNA
in the blood, detecting biological signs of cancer and then making predictions about where the cancer is and what kind of
treatments would work best.
As a result, «we are building on these findings to refine existing
treatments to boost feelings of being safe and supported
in order to improve coping with traumatic memories,» said Dr. Anke Karl, one of the authors, wrote of the
study.
At Battelle, Koper is
studying the use of nanomaterials
in membranes for water desalination and
treatment; supercapacitors (energy - storage devices that provide higher power densities than batteries); and bio-based (rather than petroleum - based) additives used for hydraulic fracturing, or fracking, to retrieve natural gas.
A new
study using lab - engineered microtumors allowed doctors to better predict if a cancer drug
treatment will work
in a patient.
Speaking of checkpoint inhibitor drugs... Merck's star cancer immunotherapy
treatment Keytruda is facing some troubling clinical trial incidents which have now compelled the Food and Drug Administration (FDA) to halt three
studies of the drug
in multiple myeloma, a rare blood cancer, after a number of patient deaths.
Private hospitals are typically the best equipped, with state - of - the art technology and doctors that have
studied in the world's best medical universities — many of them speak English and are well acquainted with the newest diagnostic and
treatment procedures... some of which may not yet be available
in the U.S., for example.
That's striking because the
treatment is part of a class called CETP medicines which haven't proven particularly successful
in previous
studies.
The growing number of people who have the disease is troubling, because there are only four approved drugs that treat symptoms of the disease, and several hopeful
treatments have failed key
studies in 2017.
Besides randomized controlled clinical trials, there are a number of ways researchers can
study how a particular cancer
treatment is playing out
in the real world: there are retrospective
studies, observational
studies, and even prospective research done using patient registries.
In a late - stage
study, Aimmune, a biotech immunotherapy allergy
treatment taken via pill, found that of the roughly 500 kids with peanut allergies between the ages of 4 - 17 who were part of the trial, 67 % of those who received the
treatment were able to tolerate 600 milligrams of peanut protein (about two to four peanuts) after about a year of
treatment, while only 4 % of those who got the placebo could tolerate that dose of peanut protein.
In the early 1990s,
study after
study confirmed that women business owners did not receive equal
treatment at financial institutions.
Pagan said that a larger, more comprehensive
study must be done before determining the drug's true impact, but if the drug's effectiveness is confirmed
in such tests, nilotinib could become the first
treatment to impede the killing of brain cells that's consistent with Parkinson's, according to NPR.
The
study is patient - funded; participants, who range
in age from late 30s through 80s, must pay $ 8,000 to take part, and live
in or travel to Monterey for
treatments and follow - up assessments.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical
studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes
in its stock price, corporate or other market conditions; fluctuations
in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
AUSTRALASIAN Gold Mines NL has given the green light to a project to commission a pilot mining and
treatment operation at its Dalgaranga tantalum project
in WA by October.The Perth - based company has completed a
study to establish a pilot operation,...
«Based on the results from these Phase 3
studies, the combination of bictegravir and FTC / TAF could represent an important advance
in triple - therapy
treatment for a broad range of HIV patients, and we look forward to submitting regulatory applications
in the U.S. and EU this year.»
Although adequate
treatment alleviates symptoms and improves productivity, one
study found that
in the short term, employees may need to take time off to attend clinical appointments or reduce their hours
in order to recover.
This test confirmed a significant positive effect of
treatment on investment
in high variance stocks, both for the cortisol administration
study (z = 2.37, P = 0.018) and the testosterone administration
study (z = 2.04, P = 0.041, see Fig.
The RadioShack proceedings offer an interesting case
study in the
treatment of unitranche lenders under two agreements among lenders that existed
in that case.
The biotech specialist said that its updated phase 2 data
in a
study of its poziotinib candidate
treatment for non-small cell lung cancer resulted
in a preliminary confirmed objective response rate and potential progression - free survival benefit
in patients with the EGFR Exon 20 Mutant form of the disease.
The
study implies that transportation companies should start implementing
in - depth assessment and
treatment of sleep apnea among truck drivers.
Patisiran was being evaluated
in a late - stage
study against a placebo for the
treatment of patients with hereditary ATTR (hATTR) amyloidosis with polyneuropathy.
Indeed,
in the last six months of the
study, «62 per cent of Housing First (HF) participants were housed all of the time... whereas 31 per cent of
treatment as usual (TAU) participants were housed all the time...» Further, «Among participants who were housed, housing quality was usually better and more consistent
in HF residences than TAU residences.»
Although Lu - PSMA - 617 put up good numbers
in its small single - arm
study, it still needs to outperform a physician's choice of approved
treatments in a much larger global trial.
Investors are therefore going to have to wait for the final ongoing
study to wrap up
in order to get any real insight into ALKS - 5461's fate as a
treatment for MDD.
In contrast, positive expectations of treatment doubled the natural physiological or biochemical effect of the opioid drug among the healthy volunteers in the stud
In contrast, positive expectations of
treatment doubled the natural physiological or biochemical effect of the opioid drug among the healthy volunteers
in the stud
in the
study.
What's missing,
in other words, is children with something actually to worry about — worries less amenable to the «low - cost
treatment» proposed by NYU's Child
Study Center.
Shai, I would encourage you to
study the way a virus like Aids changes to survive
in spite of all the
treatments we throw at it.
Lest common sense fail to convince readers that surgery is not a
treatment for a mental disorder, a Swedish
study published
in 2011 found that over the long term, 324 people who had undergone sex - reassignment surgery demonstrated an alarmingly high suicide rate and experienced considerably higher numbers of severe psychiatric problems than were present
in the general population.
At one point Oz mentions his
study of Agnon's
treatment of God, The Silence of Heaven, whose thesis is that «Agnon believes
in God and fears him, but he does not love him.»
It is pathetically significant that over 90 percent of the men
in the
study had had no systematic
treatment.
(And if the organization
in question spent time
studying the Bible
in depth, they'd would both know, and be able to effectively use the
treatment plan outlined
in the Torah.)
Professor Steve Odin's «A Metaphysics of Cumulative Penetration: Process Theory and Hua - yen Buddhism» (PS 11:65 - 82), is a highly stimulating and challenging essay not only for Whiteheadian and Buddhist
studies, but also for its comparative value.1 He has presented a searching analysis of Whiteheadian metaphysics of cumulative penetration, but his
treatment of Buddhism
in general and Hua - yen
in particular
in terms of that metaphysics leaves much to be desired, thereby marring the comparative nature of the whole essay.
Although he suggested that it be included within Practical Theology, Schleiermacher made his detailed
treatment of mission
study in his section on ethics.
On the youth and adult levels, church school curricula ought to include serious
study of mental illness, its causes,
treatment, and the church's role
in prevention.
Professor Steve Odin's «A Metaphysics of Cumulative Penetration: Process Theory and Hua - yen Buddhism» (PS 11:65 - 82), is a highly stimulating and challenging essay not only for Whiteheadian and Buddhist
studies, but also for its comparative value.1 He has presented a searching analysis of Whiteheadian metaphysics of cumulative penetration, but his
treatment of Buddhism
in general and...
Confine burgeoning expenditures to real medical research, early hospitalization costs, and scientific
studies; and reduce money's importance as a factor
in prevention,
treatment, recovery, and the sustenance of government, non-profit, business, and religious agencies.
For detailed instructions for using this exercise
in sexual therapy (and enrichment) see William Hartmann and Virginia Fifthian's
Treatment of Sexual Dysfunction (Long Beach, Calif.: Center for Marital and Sexual
Studies, 1972), pp. 98 - 138.
H. J. Clinebell, Jr «Philosophical - Religious Factors
in the Etiology and
Treatment of Alcoholism,» Quarterly Journal of
Studies on Alcohol, Vol.
Although Whitehead's theory of propositions has received
treatment in many general
studies of Whitehead's philosophy, it has received little attention as a topic by itself.
Morgan had earlier complained (EEV) about Whitehead's
treatment of mind
in CN as wholly distinct from nature, and objected to Whitehead's earlier claim that the
study of their relations constitutes metaphysics rather than philosophy of science.
What is more,
studies have shown that the mates of alcoholics are often almost as disturbed, anxious, and
in need of
treatment as the alcoholic.